Key Events This Week
Mar 30: New 52-week low at Rs.806.2 amid sector and market downturn
Apr 1: Intraday high reached Rs.866.2 with a 7.09% surge
Apr 2: Continued gains with a 1.56% rise to Rs.883.05
Apr 3: Week closes at Rs.883.05, up 5.26% for the week

Epigral Ltd Surges 7.09% to Day's High of Rs 866.2 — Outperforms Specialty Chemicals Sector by 2.36 Percentage Points
2026-04-01 11:46:57The Sensex declined by 2.20% on 1 Apr 2026, while Epigral Ltd surged 7.09%, marking a 4.89-percentage-point outperformance over the benchmark. This sharp intraday gain, reaching a high of Rs 866.2, stands out as a stock-specific event amid a broadly weak market environment.
Read full news article
Epigral Ltd is Rated Sell
2026-03-29 10:10:37Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Markets Rally, But Epigral Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-03-23 13:54:19Despite a broader market rally, Epigral Ltd has plunged to a fresh 52-week low of Rs 822 on 23 Mar 2026, marking a steep 57.05% decline over the past year and underscoring persistent headwinds unique to the stock.
Read full news article
Epigral Ltd is Rated Sell by MarketsMOJO
2026-03-18 10:11:11Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news articleEpigral Ltd Falls 3.01% Amid 52-Week Low and Market Pressure
2026-03-07 12:02:08
Key Events This Week
2 Mar: New 52-week low at Rs.822.05 amid sustained downtrend
2 Mar: Significant gap down opening of 7.93%
4 Mar: Continued decline with Rs.857.00 close (-1.58%)
6 Mar: Week closes at Rs.865.95 with a modest 1.06% gain

Epigral Ltd is Rated Sell by MarketsMOJO
2026-03-07 10:10:38Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Epigral Ltd Opens with Significant Gap Down Amid Market Concerns
2026-03-02 13:34:28Epigral Ltd, a specialty chemicals company, opened the trading session with a pronounced gap down, reflecting heightened market concerns following a series of negative performance indicators and a downgrade in its mojo grade. The stock’s opening price plunged by 7.93%, marking a fresh 52-week low and continuing a downward trend that has persisted over the past week.
Read full news articleCorporate Actions
No Upcoming Board Meetings
Epigral Ltd has declared 25% dividend, ex-date: 07 Feb 25
No Splits history available
No Bonus history available
No Rights history available







